Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women.

Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A.

Mov Disord. 2018 Sep;33(9):1492-1496. doi: 10.1002/mds.109. Epub 2018 Sep 14.

PMID:
30218460
2.

The association between restless legs syndrome and premotor symptoms of Parkinson's disease.

Iwaki H, Hughes KC, Gao X, Schwarzschild MA, Ascherio A.

J Neurol Sci. 2018 Nov 15;394:41-44. doi: 10.1016/j.jns.2018.08.028. Epub 2018 Sep 1.

PMID:
30212740
3.

Non-motor features of Parkinson's disease in a nested case-control study of US men.

Hughes KC, Gao X, Baker JM, Stephen C, Kim IY, Valeri L, Schwarzschild MA, Ascherio A.

J Neurol Neurosurg Psychiatry. 2018 Aug 3. pii: jnnp-2018-318275. doi: 10.1136/jnnp-2018-318275. [Epub ahead of print]

PMID:
30076266
4.

Association of Exposure to Diethylstilbestrol During Pregnancy With Multigenerational Neurodevelopmental Deficits.

Kioumourtzoglou MA, Coull BA, O'Reilly ÉJ, Ascherio A, Weisskopf MG.

JAMA Pediatr. 2018 Jul 1;172(7):670-677. doi: 10.1001/jamapediatrics.2018.0727.

PMID:
29799929
5.

Genetic variants related to urate and risk of Parkinson's disease.

Hughes KC, Gao X, O'Reilly EJ, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A.

Parkinsonism Relat Disord. 2018 Aug;53:4-9. doi: 10.1016/j.parkreldis.2018.04.031. Epub 2018 May 1.

PMID:
29789205
6.

Association of Maternal Exposure to Childhood Abuse With Elevated Risk for Attention Deficit Hyperactivity Disorder in Offspring.

Roberts AL, Liew Z, Lyall K, Ascherio A, Weisskopf MG.

Am J Epidemiol. 2018 Sep 1;187(9):1896-1906. doi: 10.1093/aje/kwy098.

PMID:
29762636
7.

Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.

Kim IY, O'Reilly ÉJ, Hughes KC, Gao X, Schwarzschild MA, Hannan MT, Betensky RA, Ascherio A.

Neurology. 2018 May 8;90(19):e1646-e1653. doi: 10.1212/WNL.0000000000005473. Epub 2018 Apr 11.

PMID:
29643081
8.

Urate and the risk of Parkinson's disease in men and women.

Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K.

Parkinsonism Relat Disord. 2018 Jul;52:76-82. doi: 10.1016/j.parkreldis.2018.03.026. Epub 2018 Mar 28.

PMID:
29615298
9.

Author response: 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Ascherio A, Soilu-Hänninen M, Surcel HM, Åivo J.

Neurology. 2018 Apr 3;90(14):668-669. doi: 10.1212/WNL.0000000000005245. No abstract available.

PMID:
29610235
10.

Sun exposure over the life course and associations with multiple sclerosis.

Tremlett H, Zhu F, Ascherio A, Munger KL.

Neurology. 2018 Apr 3;90(14):e1191-e1199. doi: 10.1212/WNL.0000000000005257. Epub 2018 Mar 7.

PMID:
29514944
11.

Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.

Kim IY, O'Reilly ÉJ, Hughes KC, Gao X, Schwarzschild MA, McCullough ML, Hannan MT, Betensky RA, Ascherio A.

Mov Disord. 2018 Mar;33(3):414-420. doi: 10.1002/mds.27279. Epub 2018 Jan 10.

PMID:
29318639
12.

Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.

O'Reilly ÉJ, Bjornevik K, Schwarzschild MA, McCullough ML, Kolonel LN, Le Marchand L, Manson JE, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):194-200. doi: 10.1080/21678421.2017.1418005. Epub 2017 Dec 26.

PMID:
29277115
13.

Physical activity across adulthood and subjective cognitive function in older men.

Fondell E, Townsend MK, Unger LD, Okereke OI, Grodstein F, Ascherio A, Willett WC.

Eur J Epidemiol. 2018 Jan;33(1):79-87. doi: 10.1007/s10654-017-0331-2. Epub 2017 Nov 17.

PMID:
29147949
14.

Adherence to Mediterranean diet and subjective cognitive function in men.

Bhushan A, Fondell E, Ascherio A, Yuan C, Grodstein F, Willett W.

Eur J Epidemiol. 2018 Feb;33(2):223-234. doi: 10.1007/s10654-017-0330-3. Epub 2017 Nov 17.

PMID:
29147948
15.

Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use.

Kim IY, O'Reilly ÉJ, Hughes KC, Gao X, Schwarzschild MA, Ascherio A.

J Parkinsons Dis. 2017;7(4):677-684. doi: 10.3233/JPD-171175.

PMID:
28984617
16.

Dietary antioxidants and Parkinson's disease.

Ascherio A, Schwarzschild MA.

Mov Disord. 2017 Nov;32(11):1501-1503. doi: 10.1002/mds.27194. Epub 2017 Oct 4. No abstract available.

PMID:
28976040
17.

Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".

Fitzgerald KC, Munger KL, Ascherio A.

Ann Neurol. 2017 Oct;82(4):649. doi: 10.1002/ana.25055. Epub 2017 Oct 10. No abstract available.

PMID:
28961335
18.

Research Letter: Folic acid supplementation and intake of folate in pregnancy in relation to offspring risk of autism spectrum disorder.

Strøm M, Granström C, Lyall K, Ascherio A, Olsen SF.

Psychol Med. 2018 Apr;48(6):1048-1054. doi: 10.1017/S0033291717002410. Epub 2017 Sep 26. No abstract available.

PMID:
28946926
19.

Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses.

Palacios N, Munger KL, Fitzgerald KC, Hart JE, Chitnis T, Ascherio A, Laden F.

Environ Int. 2017 Dec;109:64-72. doi: 10.1016/j.envint.2017.07.013. Epub 2017 Sep 20.

PMID:
28938101
20.

25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Hongell K, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A.

Neurology. 2017 Oct 10;89(15):1578-1583. doi: 10.1212/WNL.0000000000004489. Epub 2017 Sep 13.

21.

Air Pollution and Risk of Parkinson's Disease in a Large Prospective Study of Men.

Palacios N, Fitzgerald KC, Hart JE, Weisskopf M, Schwarzschild MA, Ascherio A, Laden F.

Environ Health Perspect. 2017 Aug 18;125(8):087011. doi: 10.1289/EHP259.

22.

No association between dietary sodium intake and the risk of multiple sclerosis.

Cortese M, Yuan C, Chitnis T, Ascherio A, Munger KL.

Neurology. 2017 Sep 26;89(13):1322-1329. doi: 10.1212/WNL.0000000000004417. Epub 2017 Aug 25.

23.

Indoor tanning bed use and risk of food addiction based on the modified Yale Food Addiction Scale.

Li WQ, E McGeary J, Cho E, Flint A, Wu S, Ascherio A, Rimm E, Field A, A Qureshi A.

J Biomed Res. 2016 Oct 17;31(1):31-39. doi: 10.7555/JBR.31.20160098.

24.

Author response: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Stenager E, Ascherio A.

Neurology. 2017 Jul 25;89(4):411. doi: 10.1212/WNL.0000000000004140. No abstract available.

PMID:
28739666
25.

Targeting urate to reduce oxidative stress in Parkinson disease.

Crotty GF, Ascherio A, Schwarzschild MA.

Exp Neurol. 2017 Dec;298(Pt B):210-224. doi: 10.1016/j.expneurol.2017.06.017. Epub 2017 Jun 13. Review.

PMID:
28622913
26.

Intake of dairy foods and risk of Parkinson disease.

Hughes KC, Gao X, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A.

Neurology. 2017 Jul 4;89(1):46-52. doi: 10.1212/WNL.0000000000004057. Epub 2017 Jun 8.

27.

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A; BENEFIT Study Group.

Ann Neurol. 2017 Jul;82(1):20-29. doi: 10.1002/ana.24965.

28.

Polyunsaturated fatty acids and the risk of multiple sclerosis.

Bjørnevik K, Chitnis T, Ascherio A, Munger KL.

Mult Scler. 2017 Dec;23(14):1830-1838. doi: 10.1177/1352458517691150. Epub 2017 Feb 3.

PMID:
28156186
29.

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A.

Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30.

30.

Intake of antioxidant vitamins and risk of Parkinson's disease.

Hughes KC, Gao X, Kim IY, Rimm EB, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A.

Mov Disord. 2016 Dec;31(12):1909-1914. doi: 10.1002/mds.26819. Epub 2016 Oct 27.

31.

Physical activity and the incidence of multiple sclerosis.

Dorans KS, Massa J, Chitnis T, Ascherio A, Munger KL.

Neurology. 2016 Oct 25;87(17):1770-1776. Epub 2016 Sep 28.

32.

The epidemiology of Parkinson's disease: risk factors and prevention.

Ascherio A, Schwarzschild MA.

Lancet Neurol. 2016 Nov;15(12):1257-1272. doi: 10.1016/S1474-4422(16)30230-7. Epub 2016 Oct 11. Review.

PMID:
27751556
33.

Serum urate at trial entry and ALS progression in EMPOWER.

O'Reilly ÉJ, Liu D, Johns DR, Cudkowicz ME, Paganoni S, Schwarzschild MA, Leitner M, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):120-125. doi: 10.1080/21678421.2016.1214733. Epub 2016 Sep 28.

34.

People with MS should consume a low-salt diet - NO.

Ascherio A, Munger KL.

Mult Scler. 2016 Dec;22(14):1779-1781. Epub 2016 Sep 8. No abstract available.

PMID:
27609133
35.

Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis.

Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL.

Neurology. 2016 Oct 4;87(14):1457-1463. Epub 2016 Sep 7.

36.

Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.

Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, Hogenesch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM.

Ann Neurol. 2016 Oct;80(4):616-24. doi: 10.1002/ana.24769.

PMID:
27554176
37.

No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study.

Thorsen SU, Pipper CB, Alberdi-Saugstrup M, Nielsen S, Cohen A, Lundqvist M, Thygesen LC, Ascherio A, Svensson J.

Scand J Rheumatol. 2017 Mar;46(2):104-111. doi: 10.1080/03009742.2016.1178325. Epub 2016 Jul 27.

PMID:
27460412
38.

Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.

Hagan KA, Munger KL, Ascherio A, Grodstein F.

Am J Public Health. 2016 Sep;106(9):1650-5. doi: 10.2105/AJPH.2016.303324. Epub 2016 Jul 26. Review.

39.

Weighing Evidence from Mendelian Randomization-Early-Life Obesity as a Causal Factor in Multiple Sclerosis?

Ascherio A, Munger KL.

PLoS Med. 2016 Jun 28;13(6):e1002054. doi: 10.1371/journal.pmed.1002054. eCollection 2016 Jun.

40.

Neonatal vitamin D status is not associated with later risk of type 1 diabetes: results from two large Danish population-based studies.

Jacobsen R, Thorsen SU, Cohen AS, Lundqvist M, Frederiksen P, Pipper CB, Pociot F, Thygesen LC, Ascherio A, Svensson J, Heitmann BL.

Diabetologia. 2016 Sep;59(9):1871-81. doi: 10.1007/s00125-016-4002-8. Epub 2016 May 30.

PMID:
27241183
41.

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Sena A, Capela C, Ferret-Sena V, Munger KL, Ascherio A, Suarez G.

Neurology. 2016 May 24;86(21):2026. doi: 10.1212/01.wnl.0000484266.87397.05. No abstract available.

PMID:
27217468
42.

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.

Ascherio A, Munger KL.

Semin Neurol. 2016 Apr;36(2):103-14. doi: 10.1055/s-0036-1579693. Epub 2016 Apr 26. Review.

PMID:
27116717
43.

New insights on physical activity and amyotrophic lateral sclerosis.

Ascherio A, O'Reilly EJ.

Eur J Epidemiol. 2016 Mar;31(3):213-5. doi: 10.1007/s10654-016-0133-y. Epub 2016 Mar 8. No abstract available.

PMID:
26955829
44.

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.

Munger KL, Åivo J, Hongell K, Soilu-Hänninen M, Surcel HM, Ascherio A.

JAMA Neurol. 2016 May 1;73(5):515-9. doi: 10.1001/jamaneurol.2015.4800.

45.

Perinatal vitamin D levels are not associated with later risk of developing pediatric-onset inflammatory bowel disease: a Danish case-cohort study.

Thorsen SU, Jakobsen C, Cohen A, Lundqvist M, Thygesen LC, Pipper C, Ascherio A, Svensson J.

Scand J Gastroenterol. 2016 Aug;51(8):927-33. doi: 10.3109/00365521.2016.1144218. Epub 2016 Feb 12.

PMID:
26872831
46.

Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease.

Bhattacharyya S, Bakshi R, Logan R, Ascherio A, Macklin EA, Schwarzschild MA.

Mov Disord. 2016 Mar;31(3):417-21. doi: 10.1002/mds.26483. Epub 2016 Jan 25.

PMID:
26805433
47.

Prospective study of plasma urate and risk of Parkinson disease in men and women.

Gao X, O'Reilly ÉJ, Schwarzschild MA, Ascherio A.

Neurology. 2016 Feb 9;86(6):520-6. doi: 10.1212/WNL.0000000000002351. Epub 2016 Jan 13.

48.

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.

Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A.

JAMA Neurol. 2015 Dec;72(12):1458-65. doi: 10.1001/jamaneurol.2015.2742.

PMID:
26458124
49.

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A.

Neurology. 2015 Nov 10;85(19):1694-701. doi: 10.1212/WNL.0000000000002099. Epub 2015 Oct 9.

50.

EBV and Autoimmunity.

Ascherio A, Munger KL.

Curr Top Microbiol Immunol. 2015;390(Pt 1):365-85. doi: 10.1007/978-3-319-22822-8_15. Review.

PMID:
26424654

Supplemental Content

Loading ...
Support Center